{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:35:06Z","timestamp":1777700106693,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00223-015-0026-1","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T08:14:02Z","timestamp":1435911242000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Early Effects of Single and Low-Frequency Repeated Administration of\u00a0Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats"],"prefix":"10.1007","volume":"97","author":[{"given":"Yukihiro","family":"Isogai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Takao-Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emika","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Nakazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ikegaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Ishizuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/jbmr.2104","volume":"28","author":"DM Black","year":"2013","unstructured":"Black DM, Schafer AL (2013) The search for the optimal anabolic osteoporosis therapy. J Bone Miner Res 28:2263\u20132265","journal-title":"J Bone Miner Res"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","volume":"20","author":"P Chen","year":"2005","unstructured":"Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB (2005) Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 20:962\u2013970","journal-title":"J Bone Miner Res"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","volume":"45","author":"SJ Glover","year":"2009","unstructured":"Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR (2009) Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone 45:1053\u20131058","journal-title":"Bone"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-008-0005-9","volume":"6","author":"JP Bilezikian","year":"2008","unstructured":"Bilezikian JP (2008) Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep 6:24\u201330","journal-title":"Curr Osteoporos Rep"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00223-010-9420-x","volume":"87","author":"SJ Gallacher","year":"2010","unstructured":"Gallacher SJ, Dixon T (2010) Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int 87:469\u2013484","journal-title":"Calcif Tissue Int"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2011-3479","volume":"97","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97:3097\u20133106","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-012-2159-7","volume":"24","author":"M Shiraki","year":"2012","unstructured":"Shiraki M, Sugimoto T, Nakamura T (2012) Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women. Osteoporos Int 24:219\u2013226","journal-title":"Osteoporos Int"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00198-013-2516-1","volume":"25","author":"T Sugimoto","year":"2014","unstructured":"Sugimoto T, Nakamura T, Nakamura Y, Isogai Y, Shiraki M (2014) Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24\u00a0weeks in postmenopausal women with osteoporosis. Osteoporos Int 25:1173\u20131180","journal-title":"Osteoporos Int"},{"key":"26_CR10","first-page":"497","volume":"36","author":"BL Riggs","year":"1984","unstructured":"Riggs BL (1984) Evidence that serum bone gla-protein is a measure of bone formation but not bone resorption. Calcif Tissue Int 36:497","journal-title":"Calcif Tissue Int"},{"key":"26_CR11","author":"R Takao-Kawabata","year":"2015","unstructured":"Takao-Kawabata R, Isogai Y, Takakura A, Shimazu Y, Sugimoto E, Nakazono O, Ikegaki I, Kuriyama H, Tanaka S, Oda H, Ishizuya T (2015) Three-times-weekly administration of teriparatide improves vertebral and peripheral bone density, microarchitecture, and mechanical properties without accelerating bone resorption in ovariectomized rats. Calcif Tissue Int. doi: 10.1007\/s00223-015-9998-0","journal-title":"Calcif Tissue Int."},{"key":"26_CR12","author":"A Sugie-Oya","year":"2015","unstructured":"Sugie-Oya A, Takakura A, Takao-Kawabata R, Sano H, Shimazu Y, Isogai Y, Yamaguchi A, Ishizuya T (2015) Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions. J Bone Miner Metab. doi: 10.1007\/s00774-015-0670-6","journal-title":"J Bone Miner Metab"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/endo-98-4-943","volume":"98","author":"JW Dietrich","year":"1976","unstructured":"Dietrich JW, Canalis EM, Maina DM, Raisz LG (1976) Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. Endocrinology 98:943\u2013949","journal-title":"Endocrinology"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jbmr.5650111003","volume":"11","author":"Y Isogai","year":"1996","unstructured":"Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T (1996) Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384\u20131393","journal-title":"J Bone Miner Res"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/endo-127-6-3111","volume":"127","author":"CG Bellows","year":"1990","unstructured":"Bellows CG, Ishida H, Aubin JE, Heersche JN (1990) Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 127:3111\u20133116","journal-title":"Endocrinology"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119491","volume":"99","author":"T Ishizuya","year":"1997","unstructured":"Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961\u20132970","journal-title":"J Clin Invest"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00774-004-0519-x","volume":"22","author":"K Tazawa","year":"2004","unstructured":"Tazawa K, Hoshi K, Kawamoto S, Tanaka M, Ejiri S, Ozawa H (2004) Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered. J Bone Miner Metab 22:524\u2013529","journal-title":"J Bone Miner Metab"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00296065","volume":"54","author":"H Tsurukami","year":"1994","unstructured":"Tsurukami H, Nakamura T, Suzuki K, Sato K, Higuchi Y, Nishii Y (1994) A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 54:142\u2013149","journal-title":"Calcif Tissue Int"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/8756-3282(95)00387-8","volume":"17","author":"YF Ma","year":"1995","unstructured":"Ma YF, Li XJ, Jee WS, McOsker J, Liang XG, Setterberg R, Chow SY (1995) Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats. Bone 17:549\u2013554","journal-title":"Bone"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-001-1086-y","volume":"72","author":"CY Li","year":"2003","unstructured":"Li CY, Jee WS, Chen JL, Mo A, Setterberg RB, Su M, Tian XY, Ling YF, Yao W (2003) Estrogen and \u201cexercise\u201d have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat. Calcif Tissue Int 72:42\u201349","journal-title":"Calcif Tissue Int"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","volume":"100","author":"PM Chavassieux","year":"1997","unstructured":"Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ (1997) Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475\u20131480","journal-title":"J Clin Invest"},{"key":"26_CR23","first-page":"2197","volume":"85","author":"KM Prestwood","year":"2000","unstructured":"Prestwood KM, Gunness M, Muchmore DB, Lu Y, Wong M, Raisz LG (2000) A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. J Clin Endocrinol Metab 85:2197\u20132202","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00774-004-0525-z","volume":"22","author":"T Miki","year":"2004","unstructured":"Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y (2004) Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1\u00a0year of treatment. J Bone Miner Metab 22:569\u2013576","journal-title":"J Bone Miner Metab"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00223-004-0039-7","volume":"75","author":"LG Ste-Marie","year":"2004","unstructured":"Ste-Marie LG, Sod E, Johnson T, Chines A (2004) Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. Calcif Tissue Int 75:469\u2013476","journal-title":"Calcif Tissue Int"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","volume":"142","author":"YL Ma","year":"2001","unstructured":"Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE (2001) Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047\u20134054","journal-title":"Endocrinology"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1359\/jbmr.090413","volume":"24","author":"PH Luiz Freitas de","year":"2009","unstructured":"de Luiz Freitas PH, Li M, Ninomiya T, Nakamura M, Ubaidus S, Oda K, Udagawa N, Maeda T, Takagi R, Amizuka N (2009) Intermittent PTH administration stimulates pre-osteoblastic proliferation without leading to enhanced bone formation in osteoclast-less c-fos(\u2013\/\u2013) mice. J Bone Miner Res 24:1586\u20131597","journal-title":"J Bone Miner Res"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/8756-3282(94)90322-0","volume":"15","author":"S Nishida","year":"1994","unstructured":"Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S, Takahashi HE (1994) Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15:717\u2013723","journal-title":"Bone"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","volume":"104","author":"RL Jilka","year":"1999","unstructured":"Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439\u2013446","journal-title":"J Clin Invest"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1210\/en.2005-1627","volume":"147","author":"T Tobimatsu","year":"2006","unstructured":"Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K (2006) Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147:2583\u20132590","journal-title":"Endocrinology"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","volume":"92","author":"R Balena","year":"1993","unstructured":"Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D et al (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577\u20132586","journal-title":"J Clin Invest"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000186151","volume":"56","author":"S Mazzaferro","year":"1990","unstructured":"Mazzaferro S, Coen G, Ballanti P, Bondatti F, Bonucci E, Pasquali M, Sardella D, Tomei E, Taggi F (1990) Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron 56:261\u2013266","journal-title":"Nephron"},{"key":"26_CR33","first-page":"1912","volume":"10","author":"P Joffe","year":"1995","unstructured":"Joffe P, Heaf JG, Jensen LT (1995) Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone. Nephrol Dial Transplant 10:1912\u20131917","journal-title":"Nephrol Dial Transplant"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-015-0026-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0026-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T23:17:47Z","timestamp":1566947867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-015-0026-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s00223-015-0026-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]}}}